Equity Rights Offering	6 Months Ended
Jun. 30, 2023
Warrants And Rights Note Disclosure [Abstract]
Equity Rights Offering	Note 10 – Equity Rights Offering In September 2020, the Corporation completed an equity-rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statements of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. For the three and six months ended June 30, 2023 and 2022, the Corporation received no proceeds from shareholders from exercise of Series A warrants.

Equity Rights Offering

6 Months Ended

Jun. 30, 2023

Warrants And Rights Note Disclosure [Abstract]

Note 10 – Equity Rights Offering

In September 2020, the Corporation completed an equity-rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statements of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. For the three and six months ended June 30, 2023 and 2022, the Corporation received no proceeds from shareholders from exercise of Series A warrants.